187 Views

Cotapaxi snags $6.5 mln Series A

Utah-based Cotopaxi, a consumer outdoor gear and apparel company, has received $6.5 million in Series A funding. Greycroft Partners led the round with participation from other investors that included New Enterprise Associates, Forerunner Ventures and Lerer Hippeau Ventures.

Board-Hero_LowRes.Orange Chef
241 Views

The smart kitchen heats up–VCJ

As smart home technology and IoT becomes widely adopted in the coming years, the smart kitchen could be a $10 billion market opportunity for VCs by 2020.

243 Views

Collective Health snags $38 mln Series B

San Mateo, California-based Collective Health, a self-insurance platform provider, has raised $38 million in Series B funding. Founders Fund and New Enterprise Associates led the round with participation from Formation 8, Redpoint Ventures, RRE Ventures, Subtraction Capital and Rock Health.

246 Views

FiftyThree snags $30 mln Series B from NEA

FiftyThree, which develops mobile tools for creation, has raised $30 million in Series B funding. The investor was New Enterprise Associates. According to the company, the capital infusion will be used for expansion.

134 Views

Champions Oncology nets $14 mln

Hackensack, New Jersey-based Champions Oncology Inc, a developer of advanced tech solutions to personalize the use of oncology drugs, has closed $14 million in funding. New Enterprise Associates led the round with participation from other investors that included Battery Ventures, Perceptive Advisors and Sabby Capital. MTS Securities, LLC, an affiliate of MTS Health Partners LP, served as the placement agent.

PhaseBio Pharmaceuticals picks up $40 mln Series C

Malvern, Pennsylvania-based PhaseBio Pharmaceuticals Inc, which is focused on developing treatments for metabolic and specialty cardiopulmonary disorders, has secured $40 million in Series C funding. AstraZeneca led the round with participation from New Enterprise Associates, Hatteras Venture Partners, Johnson & Johnson Innovation – JJDC and Fletcher Spaght Ventures. In addition to the funding, Dr. Michael Gutch of AstraZeneca has been added to PhaseBio’s board of directors while Donald Dwyer, also of AstraZeneca, has become a board observer.

165 Views

NEA, others seed enterprise productivity platform Do

Do, which provides a productivity platform for the enterprise, has raised $2 million in seed funding from New Enterprise Associates, Slow Ventures (Dave Morin and Kevin Colleran), Nas of Queensbridge Venture Partners, Zynga founder Mark Pincus, Chegg co-founder Aayush Phumbhra, Cotap CEO and former Yammer Chief Product Officer Jim Patterson, and other investors. The San Francisco-based company, which allows users to take notes, share files, assign tasks, and do related meeting tasks, launched in July 2014 with an undisclosed amount of initial backing, including from SherpaVentures and Salesforce.

128 Views

VC-backed SugarCRM buys Stitch

SugarCRM Inc has acquired San Francisco-based Stitch, a provider of personal assistant technologies that enhance productivity for mobile users. No financial terms were disclosed. SugarCRM is backed by Goldman Sachs, Draper Fisher Jurvetson, New Enterprise Associates and Walden International.

199 Views

NEA leads $13 mln Series B funding in Swiftype

New Enterprise Associates has led a $13 million Series B funding round in Swiftype, a software-as-a-service startup for web and mobile app searching. As part of the funding, NEA Partner Chetan Puttagunta will join Swiftype’s board of directors. Swiftype previously raised $7.5 million in a Series A funding in late 2013.

190 Views

NEA leads $35 mln round for Mersana

Cambridge, Massachusetts-based Mersana Therapeutics Inc, a provider of Fleximer antibody-drug conjugate technology, has secured $35 million in Series B-1 financing. New Enterprise Associates led the round with participation from Rock Springs Capital Management, Elliott Sigal, former head of R&D at Bristol-Myers Squibb, Pfizer Venture Investments and Fidelity Biosciences. Also, Mersana has appointed Anna Protopapas as president and CEO. And, Protopapas and Dr. Elaine V. Jones, executive director of Pfizer Venture Investments, have been added to Mersana’s board of directors.

Branch Metrics pulls in $15 mln Series A

Palo Alto, California-based mobile linking platform Branch Metrics has raised $15 million in Series A funding. New Enterprise Associates and Ben Narasin led the round with participation from Pejman Mar Ventures, Zach Coelius, Cowboy Ventures and TriplePoint Capital.

135 Views

GuideSpark raises $22.2 mln

GuideSpark has closed a Series C funding round $22.2 million led by Meritech Capital Partners with participation from existing investors New Enterprise Associates (NEA), Storm Ventures and IDG Ventures. Menlo Park, Calif.-based GuideSpark provides videos that aide in employee communications and engagement.

122 Views

ScienceLogic picks up $43 mln in Goldman Sachs-led round

Goldman Sachs has led a $43 million Series D funding round for ScienceLogic. The company’s previous backers New Enterprise Associates and Intel Capital also participated in the round. Headquartered in Reston, Virginia, ScienceLogic is a provider of IT monitoring software.

138 Views

Springpath seals $34 mln

Sunnyvale, California-based Springpath, a provider of enterprise-grade storage and data management software, has raised $34 million from Sequoia Capital, New Enterprise Associates and Redpoint Ventures. Springpath has been in stealth mode since May 2012.

189 Views

Moda Operandi attracts $60 mln Series E

Online luxury retailer Moda Operandi has secured $60 million in Series E funding. Fidelity Investments led the round with participation from investors that included New Enterprise Associates, Advanced Publications Inc, the parent company of Conde Nast, New Atlantic Ventures, LVMH and RRE Ventures.

Cortendo closes about $26.4 mln in a private placement

Cortendo AB has raised about $26.4 million in a private placement. The investors were RA Capital Management, New Enterprise Associates, Broadfin Capital and HealthCap. Headquartered in Göteborg, Sweden and with offices in Radnor, Pennsylvania, Cortendo is a biopharmaceutical firm focused on orphan endocrine disorders.

PE HUB Community

Join the 12514 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget